FDA issued a Warning Letter to Amgen, Inc. on 1/27/2014 as a result of this inspection.
FDA investigators audited the Amgen - Thousand Oaks, CA, United States facility and issued 3 inspectional observations (via FDA 483) on 17 Jun 2013.
Add To Cart
- Category: Medical Devices & Rad Health
- Number of Observations: 3
- Inspection end: 17 Jun 2013
- Location: Thousand Oaks, United States
- FEI: 2026154